TrialThe European respiratory journal2026

Safety and efficacy of namilumab for the treatment of chronic pulmonary sarcoidosis (RESOLVE-Lung): a randomised, double-blinded, multicentre, phase 2 study.

Bernt Van Den Blink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.